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Abstract
Background. Debilitating abdominal pain remains the most common presentation of chronic pancreatitis and the treatment
remains challenging. Objective. This prospective study analyzed the outcome of Frey’s procedure in patients with
inflammatory head mass. Methods. For the period between 2002 and 2007, 77 patients with chronic pancreatitis underwent
Frey procedure for intractable abdominal pain. The mean follow-up was 14 months. For the purpose of analysis of the
outcome, patients were grouped as poor pain control (19%) and good pain control groups (81%) based on the pain scores
during follow-up. Results. There was no 30-day mortality. The logistic regression analysis showed that decreased volume
percentage (48%) of head mass resected (p0.003) and small diameter of the pancreatic duct (p0.05) were associated
with poor pain outcome. Subgroup analysis revealed that patients with small duct disease were associated with increased
operative time (p0.001), poor pain scores (p0.001), and increased weight loss (p0.003) during follow-up. Conclusions.
Frey procedure can be performed with zero mortality and low morbidity in a high-volume center. It provides good pain
relief in majority of the patients. Volume of the head mass cored affects pain outcome. Correlation between poor results in
terms of pain relief and weight loss following Frey’s procedure, and small duct disease supports the view that duct diameter
is an important predictor of pain relief.
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Introduction
Debilitating abdominal pain remains the most com-
mon presentation and indication for surgery in patients
with chronic pancreatitis. The precise mechanism
underlying the abdominal pain is uncertain. It may
be related to ductal hypertension [1], increased par-
enchymal pressure, perineural inflammation [2] or as a
complication of the disease. Therapeutic interventions
developed to relieve the disabling pain include con-
servative [3,4] and surgical management [5]. Varied
morphology of the gland has led to the evolution of
diverse resection [6] and drainage [7] approaches.
About 1850% of patients with chronic pancreatitis
present with an inflammatory head mass [6] and its
resection was considered necessary to relieve the pain
by extirpating the ‘‘pacemaker of pain’’ [8]. Although
pancreaticoduodenectomy provided good pain con-
trol, increased long-term exocrine and endocrine
dysfunction [9] led to a growing enthusiasm for
duodenum preserving head resections [10]. In 1987,
Frey et al. reported a new technique where patients
with inflammatory head mass underwent local resec-
tion of the head of pancreas combined with long-
itudinal pancreatico-jejunostomy (LR-LPJ). Frey
procedure avoids transection at the neck of pancreas
and requires single anastomoses, as opposed to
Beger’s procedure which requires two anastomoses
[11]. Frey procedure provided good pain control
in 90% of the patients with low mortality and
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morbidity [12]. This article aims to study outcome
and short-term results of the Frey procedure in the
treatment of chronic pancreatitis.
Patients and methods
This prospective study was done at Government
Stanley Medical college Hospital, Chennai, India.
Between 2002 and 2007, 77 patients with chronic
pancreatitis underwent Frey procedure for intractable
abdominal pain. All patients had a detailed history
and clinical examination. The diagnostic workup
includes ultrasonography (USG), computed tomo-
graphic scanning (CT), and magnetic resonance
cholangiopancreatography (MRCP). The diagnosis
of chronic pancreatitis was made on the basis of a
history of typical abdominal pain and pancreatic
calcification or dilatation of main pancreatic duct on
imaging (US, CT scan, MRCP). The head of
pancreas was considered enlarged when its maximum
diameter was more than 35 mm [13]. Patients who
have completed at least six months follow-up alone
were included in the study. The main pancreatic duct
was considered small or non-dilated if it measured
5 mm or less at neck [14]. The main pancreatic
duct was considered dilated if it measured greater
than 67 mm in its maximal diameter.
Pancreatic exocrine function was assessed by the
presence of steatorrhea. Patients were requested to
answer a questionnaire about number of stools per day,
smell, appearance and color of the stools. Frequency of
more than three stools per day, nauseating smell,
greasy and pale stools was defined as steatorrhea
[15]. Diabetes mellitus was defined as blood glucose
level more than 200 mg/dL two hours after an oral
glucose load of 75 grams. Pain was assessed using a
scoring system consisting of a visual analogue scale,
frequency of pain attacks, analgesic requirement, and
time of disease-related inability to work [16].
Data collection
Data were obtained during hospital admission and
during follow-up at outpatient department by face-to-
face interview. The assessment interview recorded
demographic data, severity of pain, analgesic require-
ment, etiology of the disease endocrine and exocrine
insufficiency and co morbidities.
Surgery
Surgery was offered to those patients with intractable
pain interfering with their daily activities and not
responding to maximal medical treatment. The nature
of surgery depended on morphology of the pancreas
and its ductal system, and presence of other compli-
cations.
Surgical technique
The surgical procedure was performed as described
by Frey and Smith [17]. Intraoperative ultrasonogram
was used when there was difficulty in localization of
MPD. The head and uncinate process of pancreas
were cored out with diathermy. Antero posterior
diameter of the head mass before and after coring
was measured using calipers, and percentage of the
total volume of the head mass was calculated. After
perfect hemostasis, pancreaticojejunostomy was done
with Roux limb of jejunum using a continuous 00
polyglactin. The cored pancreatic tissue was sent for
histopathological examination. Unless major compli-
cations occurred, most patients were discharged by
ninth postoperative day. Postoperative morbidity and
mortality were considered ‘‘early’’ if they occurred
within 30 days of surgery or in the same hospital
admission and ‘‘late’’ if they appeared after 30 days of
performance of surgery.
Follow-up
The patients were followed in the outpatient depart-
ment every three months in the first year and every six
months in second year and annually afterwards. The
patients were asked to quantify their pain relief.
Patients with pain score of 12 or less were considered
to good pain control. Patients with pain score more
than 12 and requiring readmissions for pain were
considered to have poor pain control. Need for
analgesics, weight gain or loss, stool frequency and
need for antidiabetic drugs or insulin were recorded.
Follow-up ranged from 6 to 42 months.
Statistical analysis
Data were reported as mean9SD. The patients were
dichotomized into groups based on the presence of
pain during follow-up, and univariate analysis was
performed using the Pearson chi-square test for
categorical variables and the student independent
t-test for continuous variables. Backward stepwise
logistic regression analysis was performed using para-
meters found to be significant on univariate analysis.
The results were presented as odds ratio (OR) and
95% confidence interval (CI). The data were analyzed
using a statistical software package (SPSS 11.5 ver-
sion for Windows) A P-value of less than or equal to
0.05 was considered statistically significant.
Results
Seventy-seven patients were enrolled in the study.
Preoperative details of patients are shown in Table I.
The study includes 54 males (70%) and 23 females
(30%) with a mean age of 34.09911.88 years (range
1359). Tropical pancreatitis was the common etiol-
ogy in 41 patients (53%), and chronic alcohol
478 A. Amudhan et al.
ingestion was implicated in the rest of 36 patients
(47%). The mean age of tropical pancreatitis patients
was 28.17911.30 years compared with 40.8398.72
years in alcoholic chronic pancreatitis. The mean
interval between onset of symptoms and surgical
intervention was 3.8092.54 years. Twenty-two of
77 patients were diabetic and 18 patients had clinical
steatorrhea. Six patients had both exocrine and
endocrine insufficiency. Fourteen patients (18%)
had small duct disease and 63 (82%) had large ductal
system. All patients had an inflammatory head mass.
The mean diameter of the head mass was 5.5391.16
cm (range 3.67.8 cm). Head size in small duct
disease (4.2990.73 cm) was less compared to large
duct disease (5.8391.04 cm). The mean diameter of
small and large duct was 490.67 mm and 8.4692.63
mm, respectively. Histopathology of cored tissue
revealed chronic pancreatitis in all patients. Addi-
tional procedures with Frey procedure included
choledochoduodenostomy(2), splenectomy(1), chole-
cystectomy (3), and tube jejunostomy for feeding (1).
There was no 30-day mortality. In this series
significant complications occurred in 14 patients
(18%). It included pulmonary complications, wound
infection, intraperitoneal abscess, intra-abdominal
bleed, and pancreatic leak. All were managed con-
servatively except one patient who developed major
intra-abdominal bleeding on seventh postoperative
day and was managed by relaprotomy and ligature
of bleeding pancreaticoduodenal artery.
The mean hospitalization stay for the entire group
of patients was 11.293.78 days (range 924 days).
The mean follow-up was 1499.7 months (range,
642 months). Complete follow-up was obtained for
all patients. Four patient’s required hospitalization for
recurrent pain. Two patients underwent celiac plexus
blockade for pain relief. One patient died during
follow-up due to hepatic failure.
For the purpose of analysis of the outcome, patients
were grouped as poor pain control (15) and good pain
control groups (62) based on the pain scores during
follow-up. There was no significant difference be-
tween the two groups with regard to age, sex, disease
duration, etiology, exocrine and endocrine insuffi-
ciency (Table I). There was no difference in morbid-
ity, hospital stay and new onset exocrine and
endocrine insufficiency between the two groups
(Table II).
Among all the variables examined by univariate
analysis (Table III), small pancreatic head, small duct
diameter and decreased volume percentage of head
mass cored were associated with poor pain control.
The final model of logistic regression analysis
(Table IV) disclosed that decreased volume percen-
tage of head mass cored (p0.003) and small
diameter of the pancreatic duct (p0.05) were
associated with poor pain outcome.
Subgroup analysis revealed that patients with small
duct disease were associated with increased operative
time (p0.001), poor pain scores (p0.001), and
increased weight loss (p0.003) during follow-up.
Exocrine and endocrine function did not differ
between the groups (Table V).
Two patients developed diabetes mellitus. Twelve
Patients developed new exocrine insufficiency. Med-
ian increase in weight of 0.9991.58 kg was found in
Table I. Univariate analysis of demographic characteristics.
Poor pain
control (n15)
Good pain
control (n62) p-Value
Age, years (mean9SD) 32.2797.13 34.53912.77 NS
Sex
Male, number (%) 12(80%) 42(68%) NS
Female, number (%) 3(20%) 20(32%)
Disease duration, years 2.7791.59 4.0592.67 NS
Etiology
Alcoholic number (%) 6(40%) 30(48%) NS
Tropical number (%) 9(60%) 32(52%)
Diabetic, number (%) 5(33%) 17(27%) NS
Steatorrhea, number (%) 9(60%) 9(14.5%) NS
Table II. Analysis of outcome.
Poor pain
control (n15)
Good pain
control (n62) p-Value
Pain score, (mean9SD) 50.48915.03 4.2393.54 p0.001
Morbidity, number (%) 4(27%) 10(16%) NS
Hospital stay, days, (mean9SD) 11.6795.57 11.1093.22 NS
New onset diabetic, number (%) 1(7%) 1(2%) NS
New onset steatorrhoea, number (%) 3(20%) 9(15%) NS
Factors affecting outcome after Frey procedure 479
32% of patients and weight loss of 2.7091.78 kg in
39%, and no change in weight in 29%. The mean
hospital stay of the 77 patients was 11.293.78 days
(range 926).
Discussion
Surgical efforts to relieve pain associated with chronic
pancreatitis should be tailored according to diameter
of ductal system and presence or absence of inflam-
matory head mass. Traditionally, drainage procedures
were reserved for dilated duct disease. Controversy
exists in the presence of head mass, as the pancreatic
duct dips deep in to the parenchyma and drainage
procedures are ineffective [11]. Although resective
procedures like pancreaticoduodenectomy were ac-
cepted as a safe procedure for head mass, Farkas and
colleagues reported longer operating time, increased
postoperative morbidiy, longer hospital stay and lower
quality of life scores following pancreaticoduodenect-
omy compared to organ preserving resections for head
dominant disease [18]. Hence in recent years, there
has been a shift from resectional procedures toward
more organ preserving resections proposed by Beger
[10] and Frey, which combine features of resection
and drainage.
Unpredictable natural history and heterogeneity of
patient population across the world have made
comparison of different studies difficult.The study
population in this series is different compared to that
of western series in terms of etiology, age of presenta-
tion and morphology of pancreas and outcome of
intervention.
Frey procedure is accepted as a ‘‘patient friendly’’
procedure with zero mortality and a low morbidity
rates [19]. Our mortality and morbidity rates asso-
ciated with the procedure is well within the acceptable
range. Major postoperative complications in the
current series include pancreatic leakage and delayed
arterial bleeding. Arterial bleeding is a major life
threatening complication following head coring in the
range of 23% [12,20,21]. Bleeding follows erosion of
peripancreatic vessels by pancreatic fluid from an
insufficient anastomosis or due to rupture of pseu-
doaneurysm [22]. One patient required relaparotomy
and ligation of pancreaticoduodenal artery. Since the
patient presented with severe intra-abdominal bleed-
ing, angiography and embolization [22] was not
considered in this patient.
The aim of surgical treatment of chronic pancrea-
titis is control of pain and preservation of exocrine and
endocrine function. Following Frey procedure,
7080% of the patients with varying follow-up had
good pain control [11,12,23,24]. In the current series,
81% of the patients had complete pain relief and
confirmed the observation made by others. The cause
of poor pain outcome following surgery for chronic
pancreatitis are multifactorial and include inadequate
drainage of head, neuropathic changes and unrecog-
nized cancer [25]. An incidence of 1020% of
persistent recurrent symptoms has been reported
following Frey procedure [21].
Several risk factors for poor pain outcome have
been described in the literature. Chronic narcotic use,
pancreaticoduodenectomy in small ductal system,
mutiple abdominal surgeries before pancreatic inter-
vention were associated with poor outcome [23]. In a
recent report, preoperative exocrine insufficiency and
postoperative surgical complications were found to be
strongest predictors of poor pain outcome [26].
Frey and Amikura [23] advocate local resection of
head for chronic pancreatitis with head mass irrespec-
tive of ductal diameter. The correlation between duct
diameter and pain relief following surgery seem to be
controversial. Some authors have suggested that duct
diameter is crucial similar to our data [27], but there
is disagreement on this point [23].
Ramesh and colleagues [28] reported 94% pain
relief in small duct disease over a median follow-up of
39 months. Complete pain relief was obtained in 92%
Table III. Univariate analysis of disease factors.
Poor pain
control (n15)
Good pain
control (n62) p-Value
Pancreatic head size, cm (mean9SD) 4.3990.75 5.8191.08 p0.001
Pancreatic duct diameter, mm 4.4791.30 8.4292.72 p0.001
Volume percentage of head mass cored 48% 65% p0.001
Pseudocyst, number (%) 5(6.5%) 12(15.5%) NS
Associated procedures, number (%) 3(4%) 4(5%) NS
Table IV. Logistic regression analysis of factors associated with poor pain outcome.
Variable OR
95% confidence
interval p-Value
Pancreatic head size 0.25 0.041.68 p0.15
Volume percentage of head mass cored 0.82 0.720.92 p0.003
Pancreatic duct Diameter 0.54 0.291 p0.05
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following longitudinal V shaped excision in small duct
disease [29]. Our analysis shows pancreatic duct
diameter to be an vital factor responsible for poor
pain control. Among the 14 patients with small duct,
85% had poor pain outcome with mean pain scores of
56.79912.02. Pain in small duct disease is due to
multiple factors like inflamed nerves, pancreatic
fibrosis and ischemia apart from increased ductal
and parenchymal pressure. So a mere operative
decompression rarely produces adequate pain relief.
Many techniques have been attempted to provide
pain relief in small duct disease. Extended drainage by
V-shaped excision of anterior aspect of pancreas by
Izbicki et al. [29] provided complete pain relief. In
order to maintain a patent small duct anastomosis,
Cooperman advocated the technique of doubling the
diameter of small ducts by reattaching the longitudin-
ally incised duct to the surrounding parenchyma [30].
In the literature, reported outcome after surgery for
small duct pancreatitis varies considerably between
different centers, because an internationally accepted
definition of small duct disease is not available. Hence
a valid comparison of different study reports and
operative techniques is not possible. The higher
prevalence of poor pain outcome in small duct disease
may be due to other potential factors like neuroim-
mune interactions operating in the pathogenesis of
pain [31].
The mean volume percent of the head mass
resected in the present series was 62%. Although
Frey et al. [23] analyzed the relation between weight
of the cored tissue and pain relief, the amount of the
tissue cored depends on the size of the head, which is
highly variable. Hence in the current series, volume
percentage of the head mass cored was calculated and
good pain relief was obtained when around 65% of
total volume of head mass was cored. We also believe
that extensive coring may lead to increased parench-
ymal loss leading to exocrine insufficiency. This fact is
well observed in patients undergoing pancreaticoduo-
denectomies [32] and adverse effects on exocrine,
endocrine function, nutrition, and quality of life are
dependent on the amount of pancreas resected [33].
Hence an organ preserving adequate coring of the
head to drain the ductal system will suffice.
We found no statistically significant correlation
between head size and pain outcome. On the other
hand, Keus et al. [24] reported that increased
pancreatic head size was associated with good pain
outcome following duodenum preserving resection.
A number of technical considerations should be
discussed. The current data suggest that Frey proce-
dure in small duct disease is associated with increased
intraoperative time. We believe that difficulty in
localization of small eccentric ducts contributes to
the delay. Precise localization of pancreatic duct and
ductal calculi with IOUS saves considerable operating
time and avoids extensive dissection [34]. Although
traditionally suture plication and cautery is used for
coring the pancreatic head, it is associated with
significant char artifact. The use of ultrasonic aspira-
tor and dissector facilitates better visualized plane of
dissection and avoids significant char artifact [35].
Head coring can be performed safely with reduced
blood loss using ultrasonic coagulating shears (har-
monic scalpel) [36].
The current report is subject to all limitations of a
non randomized study. The chronic pancreatitis
sample studied is from a large tertiary care center
and therefore may reflect more severe disease than
patients who are seen in a primary care setting. Also
the sample size of small duct disease is small. Since it
is a short-term study, quality of life analysis was not
included in the current series.
Conclusions
In summary, Frey procedure can be performed with
zero mortality and low morbidity in a high-volume
center. It provides good pain relief in majority of the
patients. Volume of the head mass cored affects pain
outcome. Correlation between poor results in terms of
pain relief, and weight loss following Frey’s proce-
dure, and small duct disease supports the view that
duct diameter is an important predictor of pain relief.
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Table V. Analysis of small and large duct disease.
Small duct (n14) Large duct (n63) p-Value
Operative time (min) 314977.27 246957 p0.001
Morbidity, number (%) 4 (29%) 10 (16%) NS
Hospital stay, days, (mean9SD) 11.5795.85 11.1393.17 NS
Pain score, (mean9SD) 48.91919.8 5.3196.84 p0.001
New diabetic, number (%) 1 (7%) 1 (2%) NS
New steatorrhoea, number (%) 2 (14%) 10 (16%) NS
Weight gain in kg (mean9SD) 0.5791.22 1.0791.64 NS
Weight loss in kg (mean9SD) 2.2892.01 0.9191.59 p0.03
Factors affecting outcome after Frey procedure 481
References
[1] Ebbehoj N, Svendsen LB, Madsen P. Pancreatic tissue
pressure in chronic obstructive pancreatitis. Scand J Gastro-
enterol 1984;/19:/10668.
[2] Bockmann DE, Buchler M, Malfertheiner P, Beger HG.
Analysis of nerves in chronic pancreatitis. Gastroenterol
1988;94:145969.
[3] Buechler MW, Binder M, Friess H. Role of somatostatin and
its analogues in the treatment of acute and chronic pancrea-
titis. Gut 1994;/3:/5159.
[4] Carr-Locke DL. Endoscopic procedures in the treatment of
pancreatic pain. Acta Chir Scand 1990;/156:/2938.
[5] Warshaw AL, Banks PA, Fernandez-del Castillo C. AGA
technical review: treatment of pain in chronic pancreatitis.
Gastroentrol 1998;/115:/76576.
[6] Traverso LW, Kozarek RA. Pancreaticoduodenectomy for
chronic pancreatitis. Ann surg 1999;/236:/42936.
[7] Bradley EL. Long-term results of pancreatojejunostomy in
patients with chronic pancreatitis. Am J Surg 1987;/153:/
20713.
[8] Traverso LW. The surgical management of chronic pancrea-
titis: the Whipple procedure. Adv Surg 1999;/32:/2339.
[9] Izbicki JR, Bloechle C, Broering DC. Extented drainage versus
resection in surgery for chronic pancreatitis: a prospective
randomized trial comparing the longitudinal pancreaticojeju-
nostomy combined with local pancreatic head excision with
the pylorus preserving pancreatoduodenectomy. Ann Surg
1998;/228:/7719.
[10] Beger HG, Witte C, Krutezberger W, Bittner R. Experience
with duodenum-sparing pancreas head resection in chronic
pancreatitis. Chirurg 1980;51:3037.
[11] Frey CF. The surgical management of chronic pancreatitis:
the frey procedure. Adv surg 1999;/32:/4185.
[12] Pessaux P, Kianmanesh R, Regimbeau JM. Frey procedure in
the treatment of chronic pancreatitis: short-term results.
Pancreas 2006;/33(4):/3548.
[13] Strate T, Taherpour Z, Bloechle C. Long term follow-up of a
randomized trial comparing the Beger and Frey procedures for
patients suffering from chronic pancreatitis. Ann Surg 2005;/
241:/5918.
[14] Shrikande SV, Kleeff J, Friess H. Management of pain in small
duct chronic pancreatitis. J Gastrointest Surg 2006;/10:/227
33.
[15] Rault A, Sacunha A, Klopfenstein D. Pancreaticojejunal
anastomosis is preferable to pancreaticogastrostomy after
pancreaticoduodenectomy for long term outcomes of pan-
creatic exocrine function. J Am Coll Surg 2005;/201:/23944.
[16] Bloechle C, Izbicki JR, Knoefel WT. Quality of life in chronic
pancreatitis: results after duodenum  preserving resection of
the head of the pancreas. Pancreas 1995;/11:/7785.
[17] Frey CF, Smith GJ. Description and rationale of a new
operation for chronic pancreatitis. Pancreas 1987;/2:/7017.
[18] Farkas G, Leinder L, Daeoczi. Prospective randomized
comparison of organpreserving pancreatic head resection
with pylorus preserving pancreaticoduodenectomy. Langen-
becks Arch Surg 2006;/391:/33842.
[19] Izbicki JR, Bloeche C. Drainage operation as therapeutic
principle of surgical organ saving treatment of chronic
pancreatitis. Chirurug 1997;/68(9):/86573.
[20] Chaudary A, Negi SS, Massod S. Complications after Frey’s
procedure for chronic pancreatitis. Am J Surg 2004;/188:/
27781.
[21] Izbicki JR, Bloeche C, Knoefel WT. Duodenum preserving
head resections of the head of the pancreas in chronic
pancreatitis: a prospective randomized trial. Ann Surg 1995;/
221:/3508.
[22] Makoweic F, Riediger H, Euringer W. Management of delayed
visceral arterial bleeding after pancreatic head resection.
J Gastrointest Surg 2005;/9:/12939.
[23] Frey CF, Amikura K. Local resection of the head of the
pancreas combined with longitudinal pancreaticojejunostomy
in the management of patients with chronic pancreatitis. Ann
Surg 1994;/220:/492507.
[24] Keus E, van Laarhoven CJ, Eddes EH. Size of the pancreatic
head as a prognostic factor for the outcome of Beger’s
procedure for painful chronic pancreatitis. Br J Surg 2003;/
90(3):/3204.
[25] Markowitz JS, Rattner DW, Warshaw AL. Failure of sympto-
matic relief after pancreaticojejunal decompression for chronic
pancreatitis. Strategies for salvage. Arch surg 1994;/129(4):/
3749.
[26] Riediger H, Adam U, Fisher E. Long-term outcome after
resection for chronic pancreatitis in 224 patients. J Gastro-
intest Surg 2007;/11(8):/94959.
[27] Nealon WH, Thompson JC. Progressive loss of pancreatic
function in chronic pancreatitis is delayed by main pancreatic
duct decompression: a longitudinal prospective analysis of the
modified Puestow procedure. Ann Surg 1993;/217:/45868.
[28] Ramesh H, Jacob G, Lekha V, Venugopal A. Ductal drainage
with head coring in chronic pancreatitis with small-duct
disease. J Hepatobiliary Pancreat Surg 2003;10;36672.
[29] Izbicki JR, Bloeche C, Broering DC. Longitudinal V-Shaped
excision of the ventral pancres for small duct disease in severe
chronic pancreatitis. Prospective evaluation of a new surgical
procedure. Ann Surg 1998;/227:/2139.
[30] Cooperman AM. Surgery and chronic pancreatitis. Surg Clin
North Am 2001;/81:/43155.
[31] Di mola FF, Di Sebastino P. Pain and pain generation in
pancreatic diseases. Am J Surg 2007;/194:/6570.
[32] Hsu JT, Yeh CN, Hwang TL. Outcome of pancreaticoduo-
denectomy for chronic pancreatitis. J Formos Med Assoc
2005;/104(11):/8115.
[33] Frey CF, Mayer KL. Comparison of local resection of the
head of the pancreas combined with longitudinal pancreati-
cojejunostomy (Frey procedure) and duodenum-preserving
resection of the head of the pancreatic head (Beger proce-
dure). World J Surg 2003;/27(11):/121730.
[34] Brennan DD, Kruskal JB, Kane AR. Intraoperative ultrasound
of the pancreas. Ultra sound clin 2006;/1:/53345.
[35] Andersen DK, Topazian MD. Excavation of the pancreatic
head: a variation on the theme of duodenum-preserving
pancreatic head resection. Arch Surg 2004;/139:/3759.
[36] Chaudary A, Negi S, Bhojwani R. Frey’s procedure using the
harmonic scalpel. Surg Today 2005;/35(3):/2634.
482 A. Amudhan et al.
